Enviri Corporation Announces Results of 69th Annual Meeting of Stockholders
PHILADELPHIA, April 18, 2024 (GLOBE NEWSWIRE) — Enviri Corporation (NYSE: NVRI) announced the results of its 69th Annual Meeting of […]
Credicorp Ltd.: Credicorp’s “1Q24 quiet period”
Lima, April 18, 2024 (GLOBE NEWSWIRE) — Lima, PERU, April 18th, 2024 — Credicorp (NYSE: BAP) announces that in accordance […]
South Plains Financial, Inc. Announces 8% Increase to Quarterly Cash Dividend
LUBBOCK, Texas, April 18, 2024 (GLOBE NEWSWIRE) — South Plains Financial, Inc. (NASDAQ:SPFI) (“South Plains”), the parent company of City […]
LifeStance to Host First Quarter 2024 Earnings Conference Call on May 9, 2024
SCOTTSDALE, Ariz., April 18, 2024 (GLOBE NEWSWIRE) — LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers […]
Barinthus Bio Announces Topline Data from Phase 1b/2 APOLLO Trial of VTP-200 in Persistent High-Risk Human Papillomavirus (HPV) Infections
Primary safety endpoint met; VTP-200 was generally well-tolerated, with no treatment-related grade 3 or higher adverse events (AEs) or serious […]
Applied Optoelectronics Announces Date of First Quarter 2024 Financial Results Conference Call
SUGAR LAND, Texas, April 18, 2024 (GLOBE NEWSWIRE) — Applied Optoelectronics, Inc. (NASDAQ: AAOI), a leading provider of fiber-optic access […]
Alpine Income Property Trust Reports First Quarter 2024 Operating Results
WINTER PARK, Fla., April 18, 2024 (GLOBE NEWSWIRE) — Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company” or “PINE”) […]
Codexis to Report First Quarter 2024 Financial Results on May 2
REDWOOD CITY, Calif., April 18, 2024 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced […]
Array Technologies, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call
ALBUQUERQUE, N.M., April 18, 2024 (GLOBE NEWSWIRE) — Array Technologies, Inc. (the “Company” or “Array”) (Nasdaq: ARRY) today announced that […]
Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering
MIAMI, April 18, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage biotechnology company developing […]
